163 related articles for article (PubMed ID: 31668660)
1. Expression of Lmna-R225X nonsense mutation results in dilated cardiomyopathy and conduction disorders (DCM-CD) in mice: Impact of exercise training.
Cai ZJ; Lee YK; Lau YM; Ho JC; Lai WH; Wong NL; Huang D; Hai JJ; Ng KM; Tse HF; Siu CW
Int J Cardiol; 2020 Jan; 298():85-92. PubMed ID: 31668660
[TBL] [Abstract][Full Text] [Related]
2. Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death.
Yokokawa T; Ichimura S; Hijioka N; Kaneshiro T; Yoshihisa A; Kunii H; Nakazato K; Ishida T; Suzuki O; Ohno S; Aiba T; Ohtani H; Takeishi Y
BMC Cardiovasc Disord; 2019 Dec; 19(1):298. PubMed ID: 31847799
[TBL] [Abstract][Full Text] [Related]
3. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
[TBL] [Abstract][Full Text] [Related]
4. Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells.
Lee YK; Lau YM; Cai ZJ; Lai WH; Wong LY; Tse HF; Ng KM; Siu CW
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28754655
[TBL] [Abstract][Full Text] [Related]
5. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
[TBL] [Abstract][Full Text] [Related]
6. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
[TBL] [Abstract][Full Text] [Related]
7. Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.
Chandar S; Yeo LS; Leimena C; Tan JC; Xiao XH; Nikolova-Krstevski V; Yasuoka Y; Gardiner-Garden M; Wu J; Kesteven S; Karlsdotter L; Natarajan S; Carlton A; Rainer S; Feneley MP; Fatkin D
Circ Res; 2010 Feb; 106(3):573-82. PubMed ID: 20019332
[TBL] [Abstract][Full Text] [Related]
8. Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells.
Siu CW; Lee YK; Ho JC; Lai WH; Chan YC; Ng KM; Wong LY; Au KW; Lau YM; Zhang J; Lay KW; Colman A; Tse HF
Aging (Albany NY); 2012 Nov; 4(11):803-822. PubMed ID: 23362510
[TBL] [Abstract][Full Text] [Related]
9. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
[TBL] [Abstract][Full Text] [Related]
10. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
[TBL] [Abstract][Full Text] [Related]
12. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
[TBL] [Abstract][Full Text] [Related]
13. A Novel Truncating LMNA Mutation in Patients with Cardiac Conduction Disorders and Dilated Cardiomyopathy.
Kawakami H; Ogimoto A; Tokunaga N; Nishimura K; Kawakami H; Higashi H; Iio C; Kono T; Aono J; Uetani T; Nagai T; Inoue K; Suzuki J; Ikeda S; Okura T; Ohyagi Y; Tabara Y; Higaki J
Int Heart J; 2018 May; 59(3):531-541. PubMed ID: 29628476
[TBL] [Abstract][Full Text] [Related]
14. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction.
Del Monte-Monge A; Ruiz-Polo de Lara Í; Gonzalo P; Espinós-Estévez C; González-Amor M; de la Fuente-Pérez M; Andrés-Manzano MJ; Fanjul V; Gimeno JR; Barriales-Villa R; Dorado B; Andrés V
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446344
[TBL] [Abstract][Full Text] [Related]
15. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.
Sébillon P; Bouchier C; Bidot LD; Bonne G; Ahamed K; Charron P; Drouin-Garraud V; Millaire A; Desrumeaux G; Benaïche A; Charniot JC; Schwartz K; Villard E; Komajda M
J Med Genet; 2003 Aug; 40(8):560-7. PubMed ID: 12920062
[TBL] [Abstract][Full Text] [Related]
16. A novel LMNA nonsense mutation causes two distinct phenotypes of cardiomyopathy with high risk of sudden cardiac death in a large five-generation family.
Glöcklhofer CR; Steinfurt J; Franke G; Hoppmann A; Glantschnig T; Perez-Feliz S; Alter S; Fischer J; Brunner M; Rainer PP; Köttgen A; Bode C; Odening KE
Europace; 2018 Dec; 20(12):2003-2013. PubMed ID: 29947763
[TBL] [Abstract][Full Text] [Related]
17. Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease.
Jakobs PM; Hanson EL; Crispell KA; Toy W; Keegan H; Schilling K; Icenogle TB; Litt M; Hershberger RE
J Card Fail; 2001 Sep; 7(3):249-56. PubMed ID: 11561226
[TBL] [Abstract][Full Text] [Related]
18. Generation of a human induced pluripotent stem cell line derived from a patient with dilated cardiomyopathy carrying LMNA nonsense mutation.
Shimoda Y; Murakoshi N; Mori H; Xu D; Tajiri K; Hemmi Y; Sato I; Noguchi M; Nakamura Y; Hayashi Y; Ieda M
Stem Cell Res; 2022 Jul; 62():102793. PubMed ID: 35500377
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of the aging related LMNA splice variant progerin in dilated cardiomyopathy.
Messner M; Ghadge SK; Goetsch V; Wimmer A; Dörler J; Pölzl G; Zaruba MM
PLoS One; 2018; 13(4):e0196739. PubMed ID: 29702688
[TBL] [Abstract][Full Text] [Related]
20. LMNA E82K mutation activates FAS and mitochondrial pathways of apoptosis in heart tissue specific transgenic mice.
Lu D; Lian H; Zhang X; Shao H; Huang L; Qin C; Zhang L
PLoS One; 2010 Dec; 5(12):e15167. PubMed ID: 21151901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
